Physician–Pharmacist collaboration efforts centered on insulin initiation in veterans with uncontrolled type 2 diabetes has been previously described19 and intensification of anti-diabetes therapies, including insulin, has demonstrated a reduction in HbA1c20,21. This evidence concerns the gene INS and type 2 diabetes mellitus.